1-5 of 5
Bert L. Lum
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding

Richard A. Graham, Bert L. Lum, Sravanthi Cheeti, Jin Yan Jin, Karin Jorga, Daniel D. Von Hoff, Charles M. Rudin, Josina C. Reddy, Jennifer A. Low, Patricia M. LoRusso
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2512–2520.
https://doi.org/10.1158/1078-0432.CCR-10-2736
Published: 14 April 2011
View article titled, Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding
Open the PDF for Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of Irinotecan, Infusional 5-Fluorouracil, and Leucovorin (FOLFIRI) with Erlotinib (OSI-774): Early Termination Due To Increased Toxicities

Wells A. Messersmith, Daniel A. Laheru, Neil N. Senzer, Ross C. Donehower, Paula Grouleff, Theresa Rogers, Sean K. Kelley, David A. Ramies, Bert L. Lum, Manuel Hidalgo
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6522–6527.
https://doi.org/10.1158/1078-0432.CCR-04-0746
Published: 08 October 2004
View article titled, Phase I Trial of Irinotecan, Infusional 5-Fluorouracil, and Leucovorin (FOLFIRI) with Erlotinib (OSI-774): <subtitle>Early Termination Due To Increased Toxicities</subtitle>
Open the PDF for Phase I Trial of Irinotecan, Infusional 5-Fluorouracil, and Leucovorin (FOLFIRI) with Erlotinib (OSI-774): <subtitle>Early Termination Due To Increased Toxicities</subtitle> in another window
Journal Articles

Phase I and Pharmacokinetic Study of BMS-188797, a New Taxane Analog, Administered on a Weekly Schedule in Patients with Advanced Malignancies

Ranjana Advani, George A. Fisher, Bert L. Lum, Charro Jambalos, Cheryl D. Cho, Marvin Cohen, Ashwin Gollerkeri, Branimir I. Sikic
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5187–5194.
Published: 12 November 2003
View article titled, Phase I and Pharmacokinetic Study of BMS-188797, a New Taxane Analog, Administered on a Weekly Schedule in Patients with Advanced Malignancies
Open the PDF for Phase I and Pharmacokinetic Study of BMS-188797, a New Taxane Analog, Administered on a Weekly Schedule in Patients with Advanced Malignancies in another window
Journal Articles

A Phase I Trial of Doxorubicin, Paclitaxel, and Valspodar (PSC 833), a Modulator of Multidrug Resistance

Ranjana Advani, George A. Fisher, Bert L. Lum, John Hausdorff, Joanne Halsey, Manuel Litchman, Branimir I. Sikic
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (5): 1221–1229.
Published: 01 May 2001
View article titled, A Phase I Trial of Doxorubicin, Paclitaxel, and Valspodar (PSC 833), a Modulator of Multidrug Resistance
Open the PDF for A Phase I Trial of Doxorubicin, Paclitaxel, and Valspodar (PSC 833), a Modulator of Multidrug Resistance in another window
Journal Articles

A Phase I Single-Dose Trial of Gadolinium Texaphyrin (Gd-Tex), a Tumor Selective Radiation Sensitizer Detectable by Magnetic Resonance Imaging

David I. Rosenthal, Pamela Nurenberg, Carlos R. Becerra, Eugene P. Frenkel, David P. Carbone, Bert L. Lum, Richard Miller, Julie Engel, Stuart Young, Dale Miles, Markus F. Renschler
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (4): 739–745.
Published: 01 April 1999
View article titled, A Phase I Single-Dose Trial of Gadolinium Texaphyrin (Gd-Tex), a Tumor Selective Radiation Sensitizer Detectable by Magnetic Resonance Imaging
Open the PDF for A Phase I Single-Dose Trial of Gadolinium Texaphyrin (Gd-Tex), a Tumor Selective Radiation Sensitizer Detectable by Magnetic Resonance Imaging in another window